However, this meta-analysis erroneously included the study by Desai and colleagues [56] that examined the association between statins and late-stage breast cancer (i.e., incidence instead of prognosis), incorrectly classified the study by Ahern and others [49] as examining BCD instead of BCR, and also included a study by Borgquist et al. that examined all cholesterol lowering medications instead of statins exclusively [77]. The gene discussed is BCR; the disease is breast cancer.